e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Respiratory disease within hospital-based populations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The diagnosis of malignancy following a venous thromboembolic event - how high is the risk?
E. Crawford, H. Moudgil, T. Naicker, N. Ahmad, K. Srinivasan (Telford, United Kingdom)
Source:
International Congress 2014 – Respiratory disease within hospital-based populations
Session:
Respiratory disease within hospital-based populations
Session type:
Thematic Poster Session
Number:
4115
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Crawford, H. Moudgil, T. Naicker, N. Ahmad, K. Srinivasan (Telford, United Kingdom). The diagnosis of malignancy following a venous thromboembolic event - how high is the risk?. Eur Respir J 2014; 44: Suppl. 58, 4115
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Recurrence patterns for venous thromboembolism - who is most at risk?
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Confirmed pulmonary tuberculosis leading to late diagnosis of lung cancer - Study case
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Long-term impact of developing a postoperative pulmonary complications after lung surgery
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015
Miliary disease of the lung: What is your diagnosis?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
Therapeutic surgical resection of primary pulmonary artery sarcoma
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Latent tuberculosis infection and the risk of cancer: A nationwide population-based study
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
The association of lung cancer with active pulmonary tuberculosis.
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
LATE-BREAKING ABSTRACT: Cardio vascular disease and the risk of lung cancer, the HUNT study
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Evaluation of predictors of early and late mortality in 414 acute pulmonary embolism patients
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Treatment of pulmonary carcinoid: Are there new options?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept